Hyodeoxycholic Acid Reference: 20294-10 A secondary bile acid; decreases plasma VLDL and LDL cholesterol levels and reduces fasting glucose levels and atherosclerotic lesion size in LDL receptor knockout mice fed a Western diet at 1.25% in the diet; serum levels are increased in patients with Crohn’s disease or ulcerative colitis
R-(-)-Mandelic Acid Reference: 10007128-100 R-(−)-Mandelic Acid is a synthetic intermediate useful for pharmaceutical synthesis.
threo-9,10-Dihydroxyhexadecanoic acid, 5 mg Reference: 14-1627-4 Synonyms: 9,10-Dihydroxypalmitic acid; (±)-threo-9,10-Dihydroxyhexadecanoic acid
Hyodeoxycholic Acid Reference: 20294-25 A secondary bile acid; decreases plasma VLDL and LDL cholesterol levels and reduces fasting glucose levels and atherosclerotic lesion size in LDL receptor knockout mice fed a Western diet at 1.25% in the diet; serum levels are increased in patients with Crohn’s disease or ulcerative colitis
R-(-)-Mandelic Acid Reference: 10007128-25 R-(−)-Mandelic Acid is a synthetic intermediate useful for pharmaceutical synthesis.
Hyodeoxycholic Acid Reference: 20294-5 A secondary bile acid; decreases plasma VLDL and LDL cholesterol levels and reduces fasting glucose levels and atherosclerotic lesion size in LDL receptor knockout mice fed a Western diet at 1.25% in the diet; serum levels are increased in patients with Crohn’s disease or ulcerative colitis
R-(-)-Mandelic Acid Reference: 10007128-250 R-(−)-Mandelic Acid is a synthetic intermediate useful for pharmaceutical synthesis.